# An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.

> **NCT00002133** · NA · COMPLETED · sponsor: **Janssen, LP**

## Conditions studied

- Candidiasis, Oral
- HIV Infections

## Interventions

- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT00002133
- **Lead sponsor:** Janssen, LP
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002133, "An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00002133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*